Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5751)
All Articles published online
|
Apr 7, 2010 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol 2010; 16(13): 1649-1654 [PMID: 20355244 DOI: 10.3748/wjg.v16.i13.1649] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i13/1649.htm |
| Number | Citing Articles |
| 1 |
Joonas H. Kauppila, Karl Wahlin, Pernilla Lagergren, Jesper Lagergren. Neoadjuvant therapy in relation to lymphadenectomy and resection margins during surgery for oesophageal cancer. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18879-6
|
| 2 |
B. Mark Smithers, Iain Thomson. Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer. Thoracic Surgery Clinics 2013; 23(4): 509 doi: 10.1016/j.thorsurg.2013.07.005
|
| 3 |
Wei Deng, Qifeng Wang, Zefen Xiao, Lijun Tan, Zhao Yang, Zongmei Zhou, Hongxing Zhang, Dongfu Chen, Qinfu Feng, Jun Liang, Yexiong Li, Jie He, Shugeng Gao, Kelin Sun, Guiyu Cheng, Xiangyang Liu, Dekang Fang, Qi Xue, Yousheng Mao, Dali Wang, Jian Li. A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis. Oncotarget 2017; 8(25): 41102 doi: 10.18632/oncotarget.17062
|
| 4 |
Matthias P. Ebert, Wolfgang Fischbach, Stephan Hollerbach, Jens Höppner, Dietmar Lorenz, Michael Stahl, Martin Stuschke, Oliver Pech, Udo Vanhoefer, Rainer Porschen. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Zeitschrift für Gastroenterologie 2024; 62(04): 535 doi: 10.1055/a-2239-9802
|
| 5 |
Charles R. Mulligan. Multidisciplinary Management of Esophageal Cancer. Surgical Oncology Clinics of North America 2013; 22(2): 217 doi: 10.1016/j.soc.2012.12.006
|
| 6 |
Styliani Mantziari, Hugo Teixeira Farinha, Vianney Bouygues, Jean-Charles Vignal, Yannick Deswysen, Nicolas Demartines, Markus Schäfer, Guillaume Piessen. Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis. Cancers 2021; 13(9): 2104 doi: 10.3390/cancers13092104
|
| 7 |
Feng WANG, Ya-mei WANG, Wei HE, Xiang-ke LI, Fang-hui PENG, Xiao-li YANG, Qing-xia FAN. Chemoradiotherapy followed by surgery could improve the efficacy of treatments in patients with resectable esophageal carcinoma. Chinese Medical Journal 2013; 126(16): 3138 doi: 10.3760/cma.j.issn.0366-6999.20123438
|
| 8 |
Marcus W. Wiedmann, Joachim Mössner. International Manual of Oncology Practice. 2015; : 201 doi: 10.1007/978-3-319-21683-6_10
|
| 9 |
Chia-Ying Li, Pei-Ming Huang, Pei-Yi Chu, Po-Ming Chen, Mong-Wei Lin, Shuenn-Wen Kuo, Jang-Ming Lee. Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/6423297
|
| 10 |
Francesco Montagnani, Lorenzo Fornaro, Paolo Frumento, Caterina Vivaldi, Alfredo Falcone, Luisa Fioretto. Multimodality treatment of locally advanced squamous cell carcinoma of the oesophagus: A comprehensive review and network meta-analysis. Critical Reviews in Oncology/Hematology 2017; 114: 24 doi: 10.1016/j.critrevonc.2017.03.024
|
| 11 |
Yongxing Bao, Zeliang Ma, Meng Yuan, Yang Wang, Yu Men, Zhouguang Hui. Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis. Thoracic Cancer 2022; 13(17): 2515 doi: 10.1111/1759-7714.14588
|
| 12 |
Tom van den Ende, Elizabeth Smyth, Maarten C.C.M. Hulshof, Hanneke W.M. van Laarhoven. Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer. Best Practice & Research Clinical Gastroenterology 2018; : 45 doi: 10.1016/j.bpg.2018.11.005
|
| 13 |
Ravi Shridhar, Khaldoun Almhanna, Sarah E. Hoffe, Matthew Biagioli, Domenico Coppola, Kenneth L. Meredith. The American Cancer Society's Oncology in Practice. 2018; : 33 doi: 10.1002/9781118592168.ch3
|
| 14 |
Bo J. Noordman, Bas P. L. Wijnhoven, Joel Shapiro, Maarten C. C. M. Hulshof, Ate van der Gaast, Jan J. B. van Lanschot. Adenocarcinoma of the Esophagogastric Junction. 2017; : 149 doi: 10.1007/978-3-319-28776-8_16
|
| 15 |
Brian P Yaremko, David A Palma, Abigail L Erickson, Gregory Pierce, Richard A Malthaner, Richard I Inculet, A Rashid Dar, George B Rodrigues, Edward Yu. Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction. Radiation Oncology 2013; 8(1) doi: 10.1186/1748-717X-8-33
|
| 16 |
Ravi Shridhar, Reza Imani-Shikhabadi, Bonnie Davis, Oscar A. Streeter, Charles R. Thomas. Curative Treatment of Esophageal Cancer; An Evidenced Based Review. Journal of Gastrointestinal Cancer 2013; 44(4): 375 doi: 10.1007/s12029-013-9511-9
|
| 17 |
Hui-Shan Chen, Shiao-Chi Wu, Po-Kuei Hsu, Chien-Sheng Huang, Chia-Chuan Liu, Yu-Chung Wu. The Prognostic Impact of Preoperative and Postoperative Chemoradiation in Clinical Stage II and III Esophageal Squamous Cell Carcinomas. Medicine 2015; 94(25): e1002 doi: 10.1097/MD.0000000000001002
|
| 18 |
Kenneth L. Meredith, Taylor Maramara, Paige Blinn, Daniel Lee, Jamie Huston, Ravi Shridhar. Comparative Perioperative Outcomes by Esophagectomy Surgical Technique. Journal of Gastrointestinal Surgery 2020; 24(6): 1261 doi: 10.1007/s11605-019-04269-y
|
| 19 |
Subroto Paul, Nasser Altorki. Outcomes in the management of esophageal cancer. Journal of Surgical Oncology 2014; 110(5): 599 doi: 10.1002/jso.23759
|
| 20 |
Jonathan Cools-Lartigue, Lorenzo Ferri. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 391 doi: 10.1016/B978-0-323-40232-3.00038-8
|
| 21 |
Suun Sathornviriyapong, Akihisa Matsuda, Masao Miyashita, Satoshi Matsumoto, Nobuyuki Sakurazawa, Yoichi Kawano, Marina Yamada, Eiji Uchida. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis. Annals of Surgical Oncology 2016; 23(11): 3632 doi: 10.1245/s10434-016-5298-9
|
| 22 |
Shuang Qin Zhang, Victoria M. Villaflor. Esophageal Diseases. 2014; : 227 doi: 10.1007/978-3-319-04337-1_17
|
| 23 |
Yunpeng Zhao, Yongqiang Wang, Lei Shan, Chuanliang Peng, Wenhao Zhang, Xiaogang Zhao. A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86102-8
|
| 24 |
Daniel Lin, Lawrence Leichman. The Current Status of Neoadjuvant Therapy for Esophageal Cancer. Seminars in Thoracic and Cardiovascular Surgery 2014; 26(2): 102 doi: 10.1053/j.semtcvs.2014.07.002
|
| 25 |
Yafan Yang, Haomiao Li, Xiankai Chen, Jianjun Qin, Yong Li, Yaxing Shen, Ruixiang Zhang, Xiaozheng Kang, Zhen Wang, Qingfeng Zheng, Peng Luo, Yin Li, Jie He. Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma. Thoracic Cancer 2023; 14(7): 700 doi: 10.1111/1759-7714.14795
|
| 26 |
Nathalia Meireles da Costa, Sheila Coelho Soares Lima, Tatiana de Almeida Simão, Luis Felipe Ribeiro Pinto. The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma. Bioscience Reports 2013; 33(4) doi: 10.1042/BSR20130063
|
| 27 |
Amin Doosti-Irani, Kourosh Holakouie-Naieni, Abbas Rahimi-Foroushani, Mohammad Ali Mansournia, Peiman Haddad. A network meta-analysis of the treatments for esophageal squamous cell carcinoma in terms of survival. Critical Reviews in Oncology/Hematology 2018; 127: 80 doi: 10.1016/j.critrevonc.2018.05.007
|
| 28 |
Manish A. Shah, Nasser Altorki, Pretish Patel, Sebron Harrison, Adam Bass, Julian A. Abrams. Improving outcomes in patients with oesophageal cancer. Nature Reviews Clinical Oncology 2023; 20(6): 390 doi: 10.1038/s41571-023-00757-y
|
| 29 |
Richard A. Malthaner, Edward Yu, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Joel Bierer, David A. Palma, Dalilah Fortin, Richard I. Inculet, Eric Fréchette, Jacques Raphael, Stewart Gaede, Sara Kuruvilla, Jawaid Younus, Mark D. Vincent, George B. Rodrigues. The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial. Thoracic Cancer 2022; 13(13): 1898 doi: 10.1111/1759-7714.14433
|
| 30 |
Baoxing Liu, Yacong Bo, Kunlun Wang, Yang Liu, Xiance Tang, Yan Zhao, Erjiang Zhao, Ling Yuan. Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials. Oncotarget 2017; 8(12): 20410 doi: 10.18632/oncotarget.14669
|
| 31 |
Cai Xu, Mian Xi, Amy Moreno, Yutaka Shiraishi, Brian P. Hobbs, Meilin Huang, Ritsuko Komaki, Steven H. Lin. Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old. International Journal of Radiation Oncology*Biology*Physics 2017; 98(4): 811 doi: 10.1016/j.ijrobp.2017.02.097
|
| 32 |
K Kumagai, I Rouvelas, J A Tsai, D Mariosa, F Klevebro, M Lindblad, W Ye, L Lundell, M Nilsson. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. British Journal of Surgery 2014; 101(4): 321 doi: 10.1002/bjs.9418
|
| 33 |
Dan Han, Jing Tian, Junfeng Zhao, Shaoyu Hao. Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Triple Cohort Analysis Using Propensity Score Matching. International Journal of General Medicine 2023; : 5467 doi: 10.2147/IJGM.S440270
|
| 34 |
Shenglei Li, Hongtao Liu, Changying Diao, Xiaohui Wang, Ming Gao, Zongming Li, Lijie Song, Xianzheng Gao, Jing Han, Feng Wang, Wencai Li, Xinwei Han. Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis. Oncotarget 2017; 8(22): 36339 doi: 10.18632/oncotarget.16193
|
| 35 |
G. Doulami, S. Triantafyllou, N. Memos, N. Kokoroskos, N. Hasemaki, S. Katsaragakis, G. Zografos, D. Theodorou. Is there room for improvement in oesophageal cancer surgery? Results of a prospective protocol for individualization of surgical treatment. Hellenic Journal of Surgery 2015; 87(5): 368 doi: 10.1007/s13126-015-0243-0
|
| 36 |
Yichun Wang, Dongmei Ye, Mei Kang, Liyang Zhu, Shuhao Pan, Fan Wang. <p>Risk Factors and Patterns of Abdominal Lymph Node Recurrence After Radical Surgery for Locally Advanced Thoracic Esophageal Squamous Cell Cancer</p>. Cancer Management and Research 2020; : 3959 doi: 10.2147/CMAR.S249810
|
| 37 |
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Petra Lynen Jansen, Stephan Miehlke, Oliver Pech, Michael Stahl, Udo Vanhoefer, Matthias P.A. Ebert. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Zeitschrift für Gastroenterologie 2023; 61(06): e209 doi: 10.1055/a-1771-6953
|
| 38 |
Katrin M Sjoquist, Bryan H Burmeister, B Mark Smithers, John R Zalcberg, R John Simes, Andrew Barbour, Val Gebski. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. The Lancet Oncology 2011; 12(7): 681 doi: 10.1016/S1470-2045(11)70142-5
|
| 39 |
Ta-Chen Huang, Chih-Hung Hsu, Chia-Chi Lin, Yu-Kang Tu. Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer. Japanese Journal of Clinical Oncology 2015; 45(11): 1023 doi: 10.1093/jjco/hyv119
|
| 40 |
Ningbo Fan, Zhefang Wang, Chenghui Zhou, Marc Bludau, Gianmarco Contino, Yue Zhao, Christiane Bruns. Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis. eClinicalMedicine 2021; 42: 101183 doi: 10.1016/j.eclinm.2021.101183
|
| 41 |
Xiang Gu, Yizhi Ge, Jia Liu, Qian Ding, Junfeng Chu, Guangyu Tian, Xiaojun Chen. Impact of Chemotherapy on Prognosis of Resectable Pathological T3N0M0 Esophageal Cancer Patients: A Population-Based Study. Future Oncology 2021; 17(30): 3925 doi: 10.2217/fon-2020-1084
|
| 42 |
Yusen Zhu, Min Liu, Xiaojing Yun, Dongmei Wang, Yuhuan Bai, Guizhi Zhang, Bei Ji, Changchun Jing. Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer. Pathology & Oncology Research 2017; 23(3): 657 doi: 10.1007/s12253-016-0164-4
|
| 43 |
Fausto Petrelli, Gianluca Tomasello, Sandro Barni. Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers. European Journal of Cancer 2017; 76: 8 doi: 10.1016/j.ejca.2017.01.032
|
| 44 |
Yanru Mu, Hui Wang, Tao He, Li Xu, Jian Song. The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/7581799
|
| 45 |
Fredrik Klevebro, Signe Friesland, Mattias Hedman, Jon A. Tsai, Mats Lindblad, Ioannis Rouvelas, Lars Lundell, Magnus Nilsson. Neoadjuvant chemoradiotherapy may increase the risk of severe anastomotic complications after esophagectomy with cervical anastomosis. Langenbeck's Archives of Surgery 2016; 401(3): 323 doi: 10.1007/s00423-016-1409-0
|
| 46 |
N. S. Blencowe, P. Chana, R. N. Whistance, D. Stevens, N. A. C. S. Wong, S. J. Falk, J. M. Blazeby. Outcome Reporting in Neoadjuvant Surgical Trials: A Systematic Review of the Literature and Proposals for New Standards. JNCI Journal of the National Cancer Institute 2014; 106(9): dju217 doi: 10.1093/jnci/dju217
|
| 47 |
Wenwei Yang, Yaru Niu, Yongkun Sun. Current neoadjuvant therapy for operable locally advanced esophageal cancer. Medical Oncology 2023; 40(9) doi: 10.1007/s12032-023-02097-4
|
| 48 |
Yue Zhao, Rui Song, Yuanyuan Jia, Xiaoyun Zhang, Shasha Zhang, Chensi Wu, Ruixing Zhang, Zhanjun Guo. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis. Current Oncology 2022; 29(9): 6610 doi: 10.3390/curroncol29090519
|
| 49 |
Yuanwei Huang, Haidong Wang, Ganfeng Luo, Yanting Zhang, Li Wang, Ke Li. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma. International Journal of Surgery 2017; 38: 41 doi: 10.1016/j.ijsu.2016.12.035
|
| 50 |
Hailu Chen, Zhiyong Wu, Jiexin Chen, Xiaorong Lin, Chunpeng Zheng, Yanghang Fan, Zechun Zhang, Xiaodong Yao, Jianyi Wu, Liyan Xu, Enmin Li. Postoperative adjuvant therapy for resectable thoracic esophageal squamous cell carcinoma: a retrospective analysis of 426 cases. Medical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0417-6
|
| 51 |
Philip J. Smart, Kate L. Burbury, A. Craig Lynch, John R. Mackay, Alexander G. Heriot. Thromboembolism During Neoadjuvant Therapy for Gastrointestinal Cancer. American Journal of Clinical Oncology 2014; 37(6): 627 doi: 10.1097/COC.0b013e318280d78a
|
| 52 |
Po-Kuei Hsu, Hui-Shan Chen, Chia-Chuan Liu, Chien-Sheng Huang, Chih-Cheng Hsieh, Han-Shui Hsu, Shiao-Chi Wu. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. The Journal of Thoracic and Cardiovascular Surgery 2017; 154(2): 732 doi: 10.1016/j.jtcvs.2017.03.038
|
| 53 |
|
| 54 |
Takayuki Tsuji, Satoru Matsuda, Masashi Takeuchi, Hirofumi Kawakubo, Yuko Kitagawa. Updates of perioperative multidisciplinary treatment for surgically resectable esophageal cancer. Japanese Journal of Clinical Oncology 2023; 53(8): 645 doi: 10.1093/jjco/hyad051
|
| 55 |
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Petra Lynen Jansen, Stephan Miehlke, Oliver Pech, Michael Stahl, Udo Vanhoefer, Matthias P. A. Ebert. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus. United European Gastroenterology Journal 2024; 12(3): 399 doi: 10.1002/ueg2.12523
|
| 56 |
Bingwen Zou, Jing Pang, Yongmei Liu, Yong Xu, Lu Li, Lin Zhou, Jiang Zhu, Meijuan Huang, Jin Wang, Li Ren, Youlin Gong, You Lu, Longqi Chen, Feng Peng. Postoperative chemoradiotherapy improves survival in patients with stage II–III esophageal squamous cell carcinoma: An analysis of clinical outcomes. Thoracic Cancer 2016; 7(5): 515 doi: 10.1111/1759-7714.12355
|
| 57 |
Pallavi Purwar, Supriya Bambarkar, Sabita Jiwnani, George Karimundackal, Sarbani Ghosh Laskar, C. S. Pramesh. Multimodality Management of Esophageal Cancer. Indian Journal of Surgery 2014; 76(6): 494 doi: 10.1007/s12262-014-1163-x
|
| 58 |
Sandro Pasquali, Guang Yim, Ravinder S. Vohra, Simone Mocellin, Donald Nyanhongo, Paul Marriott, Ju Ian Geh, Ewen A. Griffiths. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma. Annals of Surgery 2017; 265(3): 481 doi: 10.1097/SLA.0000000000001905
|
| 59 |
Ari Rosenberg, Victoria M. Villaflor. Esophageal Cancer. 2018; : 193 doi: 10.1007/978-3-319-91830-3_21
|
| 60 |
Da Zhou, Donglai Chen, Peidong Song, Zihao Hu, Sukai Xu, Rongying Zhu, Yongbing Chen. Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis. Journal of Evidence-Based Medicine 2024; 17(3): 559 doi: 10.1111/jebm.12634
|
| 61 |
Balamurugan A Vellayappan, Yu Yang Soon, Geoffrey Y Ku, Cheng Nang Leong, Jiade J Lu, Jeremy CS Tey. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. Cochrane Database of Systematic Reviews 2017; 2017(8) doi: 10.1002/14651858.CD010511.pub2
|
| 62 |
Hai-Yu Zhou, Shao-Peng Zheng, An-Lin Li, Quan-Long Gao, Qi-Yun Ou, Yong-Jian Chen, Shao-Tao Wu, Da-Gui Lin, Sheng-Bo Liu, Lu-Yu Huang, Fa-Sheng Li, Hong-Yuan Zhu, Gui-Bin Qiao, Michael Lanuti, He-Rui Yao, Yun-Fang Yu. Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study). eClinicalMedicine 2020; 24: 100422 doi: 10.1016/j.eclinm.2020.100422
|
| 63 |
Cheng-Che Tu, Po-Kuei Hsu. Current choices and prospects in management of postoperative esophageal cancer patients. Asian Journal of Surgery 2019; 42(1): 81 doi: 10.1016/j.asjsur.2018.06.009
|
| 64 |
Jiaying Deng, Chunyu Wang, Mingqiong Xiang, Fatao Liu, Yun Liu, Kuaile Zhao. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-151
|
| 65 |
Yichun Wang, Fan Wang. <p>Postoperative Radiotherapy for Thoracic Esophageal Carcinoma with Upfront R0 Esophagectomy</p>. Cancer Management and Research 2020; : 13023 doi: 10.2147/CMAR.S286074
|
| 66 |
Zixian Jin, Jian Zhang, Dong Chen, Sikai Wu, Penglai Xue, Kanghao Zhu, Congcong Xu, Chengchu Zhu, Bo Zhang. Neoadjuvant chemoradiotherapy, chemotherapy, and radiotherapy do not significantly increase the incidence of anastomotic leakage after esophageal cancer surgery: a meta-analysis. Diseases of the Esophagus 2022; 35(9) doi: 10.1093/dote/doab089
|
| 67 |
David A. Palma, George B. Rodrigues, Richard Malthaner. When randomized trials and observational data disagree: The case of preoperative versus postoperative chemoradiotherapy for esophageal cancer. Cancer 2013; 119(11): 2081 doi: 10.1002/cncr.28080
|
| 68 |
Yuko Kitagawa, Takashi Uno, Tsuneo Oyama, Ken Kato, Hiroyuki Kato, Hirofumi Kawakubo, Osamu Kawamura, Motoyasu Kusano, Hiroyuki Kuwano, Hiroya Takeuchi, Yasushi Toh, Yuichiro Doki, Yoshio Naomoto, Kenji Nemoto, Eisuke Booka, Hisahiro Matsubara, Tatsuya Miyazaki, Manabu Muto, Akio Yanagisawa, Masahiro Yoshida. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus 2019; 16(1): 1 doi: 10.1007/s10388-018-0641-9
|
| 69 |
Manish A. Shah, Erin B. Kennedy, Daniel V. Catenacci, Dana C. Deighton, Karyn A. Goodman, Narinder K. Malhotra, Christopher Willett, Brendon Stiles, Prateek Sharma, Laura Tang, Bas P. L. Wijnhoven, Wayne L. Hofstetter. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. Journal of Clinical Oncology 2020; 38(23): 2677 doi: 10.1200/JCO.20.00866
|
| 70 |
Jie Zhu, Jin Tao, Zhen Dai, Yan Tan, Li Jiang, Qifeng Wang, Jinyi Lang. Progression-Free Survival as Early Efficacy Endpoint in Resectable Esophageal Cancer Treated With Neoadjuvant Therapy: A Systematic Review. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.771546
|
| 71 |
Hiroshi Saeki, Yuichiro Nakashima, Yoko Zaitsu, Yasuo Tsuda, Yuta Kasagi, Koji Ando, Yu Imamura, Kippei Ohgaki, Shuhei Ito, Yasue Kimura, Akinori Egashira, Eiji Oki, Masaru Morita, Yoshihiko Maehara. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Surgery Today 2016; 46(3): 261 doi: 10.1007/s00595-015-1144-0
|
| 72 |
Xin Xiao, Hyokyoung G. Hong, Xiaoxi Zeng, Yu‐Shang Yang, Si‐Yuan Luan, Yi Li, Long‐Qi Chen, Yong Yuan. The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta‐Analysis. World Journal of Surgery 2020; 44(12): 4161 doi: 10.1007/s00268-020-05721-w
|
| 73 |
Zixian Jin, Jiajing Sun, Jian Zhang, Jianfei Shen, Bo Zhang. Effect of preoperative radiotherapy on the prognosis of patients with stage cTxN0M0 esophageal squamous cell carcinoma: propensity score matching analysis based on SEER database. Frontiers in Surgery 2023; 10 doi: 10.3389/fsurg.2023.1052932
|
| 74 |
Wade T. Iams, Victoria M. Villaflor. Neoadjuvant Treatment for Locally Invasive Esophageal Cancer. World Journal of Surgery 2017; 41(7): 1719 doi: 10.1007/s00268-017-3959-x
|
| 75 |
H. Luo, Y. Y. Cui, J. G. Zhang, Y. N. Sun, X. L. Zheng, C. L. Yang, K. Ye, H. Ge. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma. Clinical and Translational Oncology 2018; 20(7): 889 doi: 10.1007/s12094-017-1803-2
|
| 76 |
Subroto Paul, Nasser Altorki. Induction Therapy for Esophageal Cancer. Thoracic Surgery Clinics 2013; 23(4): 499 doi: 10.1016/j.thorsurg.2013.07.007
|
| 77 |
Dong-Bin Wang, Zhong-Yi Sun, Li-Min Deng, De-Qing Zhu, Hong-Gang Xia, Peng-Zhi Zhu. Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma. Chinese Medical Journal 2016; 129(24): 2974 doi: 10.4103/0366-6999.195464
|
| 78 |
Shegan Gao, Yiwen Liu, Xiaoxian Duan, Ke Liu, Muddasir Mohammed, Zhen Gu, Junling Ren, Lan Yakoumatos, Xiang Yuan, Lanhai Lu, Shuang Liang, Jiong Li, David A. Scott, Richard J. Lamont, Fuyou Zhou, Huizhi Wang. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy. British Journal of Cancer 2021; 125(3): 433 doi: 10.1038/s41416-021-01419-5
|
| 79 |
Hsin‐Yuan Fang, Yu‐Sen Lin, Chien‐Kuang Chen, Jian‐Xun Chen, Ting‐Yu Lu, Tzu‐Min Huang, Te‐Chun Hsieh, Yu‐Cheng Kuo, Chen‐Yuan Lin, Ming‐Yu Lien, Chi‐Ching Chen, Chia‐Chin Li, Chun‐Ru Chien. Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography‐staged esophageal squamous cell carcinoma after complete resection: A population‐based cohort study. Thoracic Cancer 2022; 13(13): 1986 doi: 10.1111/1759-7714.14476
|
| 80 |
Ravi Shridhar, Jill Weber, Sarah E. Hoffe, Khaldoun Almhanna, Richard Karl, Kenneth Meredith. Adjuvant Radiation Therapy and Lymphadenectomy in Esophageal Cancer: A SEER Database Analysis. Journal of Gastrointestinal Surgery 2013; 17(8): 1339 doi: 10.1007/s11605-013-2192-7
|
| 81 |
Jaffer A. Ajani, Lisa Leung, Prianka Singh, Murat Kurt, Inkyu Kim, Mir-Masoud Pourrahmat, Steve Kanters. Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis. European Journal of Cancer 2022; 170: 119 doi: 10.1016/j.ejca.2022.04.027
|
| 82 |
Patrick M. Forde, Ronan J. Kelly. Chemotherapeutic and Targeted Strategies for Locally Advanced and Metastatic Esophageal Cancer. Journal of Thoracic Oncology 2013; 8(6): 673 doi: 10.1097/JTO.0b013e31828b5172
|
| 83 |
Jonathan Cools-Lartigue, Lorenzo Ferri. Should Multidisciplinary Treatment Differ for Esophageal Adenocarcinoma Versus Esophageal Squamous Cell Cancer?. Annals of Surgical Oncology 2019; 26(4): 1014 doi: 10.1245/s10434-019-07162-9
|
| 84 |
P-K Hsu, H-S Chen, C-S Huang, C-C Liu, C-C Hsieh, H-S Hsu, Y-C Wu, S-C Wu. Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma. Journal of British Surgery 2017; 104(1): 90 doi: 10.1002/bjs.10334
|
| 85 |
Satoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, Nobutoshi Ando, Yuko Kitagawa. Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan. Annals of Thoracic and Cardiovascular Surgery 2016; 22(5): 275 doi: 10.5761/atcs.ra.16-00111
|
| 86 |
Dimitrios Theodorou, Georgia Doulami, Nikolaos Memos, Nikolaos Kokoroskos, Gavriella-Zoi Vrakopoulou, Stamatina Triantafyllou, Eleftheria Kleidi, Stylianos Katsaragakis, George Zografos. Is there room for improvement in esophageal cancer surgery? Results of a prospective protocol for individualization of surgical treatment. Esophagus 2014; 11(4): 258 doi: 10.1007/s10388-014-0440-x
|
| 87 |
Yichun Wang, Liyang Zhu, Wanli Xia, Liming Wu, Fan Wang. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa–IVa lower thoracic oesophageal squamous cell carcinoma. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-018-1516-1
|
| 88 |
Tarun Kumar, Esha Pai, Rajesh Singh, Neville J. Francis, Manoj Pandey. Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01830-x
|
| 89 |
Zeliang Ma, Meng Yuan, Yongxing Bao, Yang Wang, Yu Men, Zhouguang Hui. Survival of Neoadjuvant and Adjuvant Therapy Compared With Surgery Alone for Resectable Esophageal Squamous Cell Carcinoma: A Systemic Review and Network Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.728185
|
| 90 |
Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, Pierre Thirion, Matthew Nankivell, Kathryn Winter, Hong Yang, Joel Shapiro, Dewi Vernerey, B. Mark Smithers, Thomas Walsh, Guillaume Piessen, Magnus Nilsson, Jurjen Boonstra, Marc Ychou, Simon Law, David Cunningham, Florent de Vathaire, Michael Stahl, Susan Urba, Michele Valmasoni, Danièle Williaume, Janine Thomas, Florian Lordick, Joel Tepper, Jack Roth, Val Gebski, Bryan Burmeister, Xavier Paoletti, Johanna van Sandick, Jianhua Fu, Jean-Pierre Pignon, Michel Ducreux, Stefan Michiels, Chanvitan Apinop, Anne Arezina, Emilie Barbier, Gary Bass, Pierre Blanchard, Jurjen Boonstra, Jean-François Bosset, Bryan H. Burmeister, Armel Maurice Cheugoua-Zanetsie, David Cunningham, Michel Ducreux, Matthieu Faron, Jianhua Fu, Val Gebski, D. J. Girling, David Kelsen, Fredrik Klevebro, Simon Law, Elisabeth Le Prise, Florian Lordick, Tanaphon Maipang, Murielle Mauer, Stefan Michiels, Jennifer Moughan, Matthew Nankivell, Knut Nygaard, Patrick Owens, Xavier Paoletti, Guillaume Piessen, Jean Pierre Pignon, Jean-Luc Raoul, Jack Roth, Alberto Ruol, Peter Schlag, Christoph Schumacher, Joel Shapiro, B. Mark Smithers, Michael Stahl, Joel Tepper, Pierre Thirion, Janine M. Thomas, Jayne Tierney, Susan Urba, Michele Valmasoni, Ate van der Gaast, Johanna van Sandick, Danièle Williaume, Kathryn Winter, John Wong, Hong Yang, Marc Ychou. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. Journal of Clinical Oncology 2023; 41(28): 4535 doi: 10.1200/JCO.22.02279
|
| 91 |
Kourosh Holakouie-Naieni, Mohammad Ali Mansournia, Amin Doosti-Irani, Abbas Rahimi-Foroushani, Peiman Haddad. Treatment-related complications in patients with esophageal cancer: A systematic review and network meta-analysis. The Surgeon 2021; 19(1): 37 doi: 10.1016/j.surge.2020.01.010
|
| 92 |
Kai Zhu, Peng Ren, Yueyang Yang, Ying Wang, Wanyi Xiao, Hongdian Zhang, Zhentao Yu. Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score‐matched analysis. Thoracic Cancer 2021; 12(12): 1800 doi: 10.1111/1759-7714.13981
|
| 93 |
Zixian Jin, Dong Chen, Meng Chen, Chunguo Wang, Bo Zhang, Jian Zhang, Chengchu Zhu, Jianfei Shen. (Neo)adjuvant Chemoradiotherapy is Beneficial to the Long‐term Survival of Locally Advanced Esophageal Squamous Cell Carcinoma: A Network Meta‐analysis. World Journal of Surgery 2022; 46(1): 136 doi: 10.1007/s00268-021-06301-2
|
| 94 |
K. Kataoka, K. Nakamura, J. Mizusawa, K. Kato, J. Eba, H. Katayama, T. Shibata, H. Fukuda. Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis. European Journal of Surgical Oncology (EJSO) 2017; 43(10): 1956 doi: 10.1016/j.ejso.2017.06.017
|
| 95 |
Lawrence M. Knab, Jim Belotte, Hidayatullah G. Munshi, David J. Bentrem. Comparative Effectiveness in Surgical Oncology. Cancer Treatment and Research 2015; 164: 121 doi: 10.1007/978-3-319-12553-4_8
|
| 96 |
Tingting Liu, Silu Ding, Jun Dang, Hui Wang, Jun Chen, Guang Li. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1388-8
|
| 97 |
Piyush Kumar, Ankita Mehta. Esophageal cancer: Treatment challenges and controversies. Journal of Current Oncology 2021; 4(1): 41 doi: 10.4103/jco.jco_13_21
|
| 98 |
Hong Yang, Hui Liu, Yuping Chen, Chengchu Zhu, Wentao Fang, Zhentao Yu, Weimin Mao, Jiaqing Xiang, Yongtao Han, Zhijian Chen, Haihua Yang, Jiaming Wang, Qingsong Pang, Xiao Zheng, Huanjun Yang, Tao Li, Florian Lordick, Xavier Benoit D’Journo, Robert J. Cerfolio, Robert J. Korst, Nuria M. Novoa, Scott J. Swanson, Alessandro Brunelli, Mahmoud Ismail, Hiran C. Fernando, Xu Zhang, Qun Li, Geng Wang, Baofu Chen, Teng Mao, Min Kong, Xufeng Guo, Ting Lin, Mengzhong Liu, Jianhua Fu. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. Journal of Clinical Oncology 2018; 36(27): 2796 doi: 10.1200/JCO.2018.79.1483
|
| 99 |
Xi Zhou, Shuzhong Liu, Zhen Huo, Siyuan Yao, Yipeng Wang, Yong Liu. Clinical characteristics and surgical treatment of esophageal cancer spinal metastasis – A single center 10-year retrospective study. Clinical Neurology and Neurosurgery 2020; 197: 106071 doi: 10.1016/j.clineuro.2020.106071
|
| 100 |
Qiwei Yao, Hongying Zheng, Shuyun Huang, Mingqiang Lin, Jun Yang, Jiancheng Li. Low versus high dose of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score‐matched analysis. Precision Radiation Oncology 2023; 7(2): 101 doi: 10.1002/pro6.1192
|
| 101 |
Ravi Shridhar, Khaldoun Almhanna, Kenneth L. Meredith, Matthew C. Biagioli, Michael D. Chuong, Alex Cruz, Sarah E. Hoffe. Radiation Therapy and Esophageal Cancer. Cancer Control 2013; 20(2): 97 doi: 10.1177/107327481302000203
|
| 102 |
Yafan Yang, Yin Li, Jianjun Qin, Ruixiang Zhang, Xiankai Chen, Jie He, Shugeng Gao. Mapping of Lymph Node Metastasis From Thoracic Esophageal Cancer: A Retrospective Study. Annals of Surgical Oncology 2022; 29(9): 5681 doi: 10.1245/s10434-022-11867-9
|
| 103 |
Andrzej Wojcieszynski, Nandita Mitra, Smith Apisarnthanarax. Reply to When randomized trials and observational data disagree: The case of preoperative versus postoperative chemoradiotherapy for esophageal cancer. Cancer 2013; 119(11): 2082 doi: 10.1002/cncr.28079
|
| 104 |
Kelvin K. W. Chan, Ronak Saluja, Keemo Delos Santos, Kelly Lien, Keya Shah, Gemma Cramarossa, Xiaofu Zhu, Rebecca K.S. Wong. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis. International Journal of Cancer 2018; 143(2): 430 doi: 10.1002/ijc.31312
|
| 105 |
P. J. Smart, L. L. Stocchi, F. H. Remzi. Neoadjuvant chemoradiation for rectal cancer is not associated with higher rates of thromboembolism. Colorectal Disease 2015; 17(11): 984 doi: 10.1111/codi.13001
|
| 106 |
Yu Liu, Deyao Xie, Chang Li, Chaoxi Lin, Jun Zhao. Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma. Oncology Letters 2017; 14(3): 2803 doi: 10.3892/ol.2017.6515
|
| 107 |
Bingwen Zou, Yan Tu, Duwen Liao, Yong Xu, Jin Wang, Meijuan Huang, Li Ren, Jiang Zhu, Youling Gong, Yongmei Liu, Lin Zhou, Xiaojuan Zhou, Feng Peng, You Lu. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?. Thoracic Cancer 2020; 11(3): 631 doi: 10.1111/1759-7714.13307
|
| 108 |
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Petra Lynen Jansen, Stephan Miehlke, Oliver Pech, Michael Stahl, Udo Vanhoefer, Matthias P.A. Ebert. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Zeitschrift für Gastroenterologie 2023; 61(06): 701 doi: 10.1055/a-1771-7087
|
| 109 |
Shin‐ichi Kosugi, Hiroshi Ichikawa, Tatsuo Kanda, Kazuhito Yajima, Takashi Ishikawa, Katsuyoshi Hatakeyama. Clinicopathological characteristics and prognosis of patients with esophageal carcinoma invading adjacent structures found during esophagectomy. Journal of Surgical Oncology 2012; 105(8): 767 doi: 10.1002/jso.22092
|
| 110 |
Cai Xu, Mian Xi, Ritsuko Komaki, Peter A. Balter, Meilin Huang, Brian P. Hobbs, Luhua Wang, Steven H. Lin. Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus. Advances in Radiation Oncology 2017; 2(3): 325 doi: 10.1016/j.adro.2017.03.006
|
| 111 |
Phillip G. Rowse, Dawn E. Jaroszewski, Mathew Thomas, Kristi Harold, William S. Harmsen, K. Robert Shen. Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer. The Annals of Thoracic Surgery 2017; 104(4): 1147 doi: 10.1016/j.athoracsur.2017.05.030
|
| 112 |
Hong Yang, Hui Liu, Yuping Chen, Chengchu Zhu, Wentao Fang, Zhentao Yu, Weimin Mao, Jiaqing Xiang, Yongtao Han, Zhijian Chen, Haihua Yang, Jiaming Wang, Qingsong Pang, Xiao Zheng, Huanjun Yang, Tao Li, Xu Zhang, Qun Li, Geng Wang, Baofu Chen, Teng Mao, Min Kong, Xufeng Guo, Ting Lin, Mengzhong Liu, Jianhua Fu. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma. JAMA Surgery 2021; 156(8): 721 doi: 10.1001/jamasurg.2021.2373
|
| 113 |
Haiming Feng, Ye Zhao, Tao Jing, Jianxing Ma, Yinglu Zhao, Jianhua Zhang, Cheng Wang, Bin Li. Traditional and cumulative meta‑analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinoma. Molecular and Clinical Oncology 2017; doi: 10.3892/mco.2017.1534
|
| 114 |
Pankaj Kumar Garg, Jyoti Sharma, Ashish Jakhetiya, Aakanksha Goel, Manish Kumar Gaur. Preoperative therapy in locally advanced esophageal cancer. World Journal of Gastroenterology 2016; 22(39): 8750-8759 doi: 10.3748/wjg.v22.i39.8750
|
| 115 |
B.M. Eyck, B.J. van der Wilk, S.M. Lagarde, B.P.L. Wijnhoven, R. Valkema, M.C.W. Spaander, J.J.M.E. Nuyttens, A. van der Gaast, J.J.B. van Lanschot. Neoadjuvant chemoradiotherapy for resectable oesophageal cancer. Best Practice & Research Clinical Gastroenterology 2018; : 37 doi: 10.1016/j.bpg.2018.11.007
|
| 116 |
Amin Doosti-Irani, Mohammad Ali Mansournia, Abbas Rahimi-Foroushani, Peiman Haddad, Kourosh Holakouie-Naieni. Local recurrence of esophageal squamous cell carcinoma after treatment: Comparison of frequentist and Bayesian network meta-analysis. Clinical Epidemiology and Global Health 2019; 7(2): 145 doi: 10.1016/j.cegh.2018.02.009
|
| 117 |
Meng Yuan, Yongxing Bao, Zeliang Ma, Yu Men, Yang Wang, Zhouguang Hui. The Optimal Treatment for Resectable Esophageal Cancer: A Network Meta-Analysis of 6168 Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.628706
|